BABATUNDE OGUNDIPE: Open Payments
NPI 1497911267 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,108 in 238 payments from 20 companies in 2025. Trend: 2023 $16,417 · 2024 $9,437 · 2025 $4,108
Food & beverage: $4,108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $727 |
| Otsuka America Pharmaceutical, Inc. | 23 | $351 |
| E.R. Squibb & Sons, L.L.C. | 19 | $344 |
| Axsome Therapeutics, Inc. | 19 | $328 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $326 |
| Tris Pharma Inc | 11 | $307 |
| Neurocrine BioSciences, Inc. | 13 | $276 |
| Lundbeck LLC | 19 | $223 |
| Corium, LLC | 12 | $223 |
| Bausch Health US, LLC | 12 | $213 |
Products named: VRAYLAR, REXULTI, COBENFY, Auvelity, CAPLYTA, Dyanavel XR, INGREZZA, Azstarys.
Industry payments across IL — which companies pay providers there.
